ABL Bio Inc.

₩36,050As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:298380Healthcare
Country South Korea
PE (Fwd) •••
TSR 8Y CAGR 7.79%
Div yield —
ROE (44.26%)
Biotechnology
Beta (5Y) 0.35
PE TTM —
TSR TTM (63.84%)
Mkt cap ₩2.018T
ROIC (23.58%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩42,244
17.18%
129.89%
Hold 10|4|3|12|5
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
657.28
687.29
718.02
804.16
19.78%
27.40%
23.28%
33.51%
Revenue₩B
196.6
197.5
207.6
210.9
9.38%
11.17%
13.77%
9.32%
Peers (US$1.488B)
Cap (US$)
PE
1.673B
—
1.493B
16.26x
Capital
TTM
5Y
10Y
Leveragex
0.658
0.379
0.427
EBIT/Intx
12.81
0.034
0.040
Own earn%
(141.97)
(110.14)
(84.36)
Sh yield%
36.99
16.43
18.73
Owners
Insiders/Inst%
14.73
70.45
Short interest%
2.52
SBC / revenue%
5.79
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
0–4
$1 testx
—
Incr. ROIC%
1